Buscador de publicaciones

La producción científica de nuestros investigadores es muy elevada. En 2022 se publicaron 1.629 artículos en revistas científicas con un factor de impacto global que superó los 15.000 puntos.

Penile Squamous Cell Carcinoma.

PMID: 22261674
Revista: Actas dermo-sifiliograficas
Año: 2012
Referencia: Actas Dermosifiliogr. 2012 Jul-Aug;103(6):478-87. doi: 10.1016/j.ad.2011.08.008. Epub 2012 Jan 17.
Factor de impacto:
Tipo de publicación: Carta o abstract
Autores: ; ; et al.
DOI: 10.1016/j.ad.2011.08.008

[Perception of work environment of nurses in hospitals of the Spanish national health system. RN4CAST-Spain project].

PMID: 23043730
Revista: Enfermeria clinica
Año: 2012
Referencia: Enferm Clin. 2012 Sep;22(5):261-8. doi: 10.1016/j.enfcli.2012.09.001. Epub 2012 Oct 6.
Factor de impacto:
Tipo de publicación: Carta o abstract
Autores: Fuentelsaz-Gallego, Carmen, Moreno-Casbas, Teresa, Lopez-Zorraquino, David, Gomez-Garcia, Teresa, Gonzalez-Maria, Esther et al.
DOI: 10.1016/j.enfcli.2012.09.001

[Perception of work environment of nurses in hospitals of the Spanish national health system. RN4CAST-Spain project].

PMID: 23043730
Revista: Enfermeria clinica
Año: 2012
Referencia: Enferm Clin. 2012 Sep;22(5):261-8. doi: 10.1016/j.enfcli.2012.09.001. Epub 2012 Oct 6.
Factor de impacto:
Tipo de publicación: Carta o abstract
Autores: Fuentelsaz-Gallego, Carmen; Gomez-Garcia, Teresa; Gonzalez-Maria, Esther; Lopez-Zorraquino, David; Moreno-Casbas, Teresa et al.
DOI: 10.1016/j.enfcli.2012.09.001

Percutaneous interface biopsy in dry-aspiration cases of chronic periprosthetic joint infections: A technique for preoperative isolation of the infecting organism.

PMID: 22124526
Revista: INTERNATIONAL ORTHOPAEDICS
Año: 2012
Referencia: Int Orthop. 2012 Jun;36(6):1281-6. Epub 2011 Nov 30.
Factor de impacto: 2.025
Tipo de publicación: Artículo en revista internacional
Autores: , , , , , , et al.
DOI: 10.1007/s00264-011-1418-0

Percutaneous interface biopsy in dry-aspiration cases of chronic periprosthetic joint infections: A technique for preoperative isolation of the infecting organism.

PMID: 22124526
Revista: INTERNATIONAL ORTHOPAEDICS
Año: 2012
Referencia: Int Orthop. 2012 Jun;36(6):1281-6. Epub 2011 Nov 30.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: ; ; ; ; ; ; et al.
DOI: 10.1007/s00264-011-1418-0

Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases.

PMID: 22402756
Revista: GENETICS IN MEDICINE
Año: 2012
Referencia: Genet Med. 2012 Jul;14(7):670-80. doi: 10.1038/gim.2012.18. Epub 2012 Mar 8.
Factor de impacto: 4.762
Tipo de publicación: Artículo en revista internacional
Autores: Casey, Graham, Mercado, Rowena C, Hampel, Heather, Kastrinos, Fay, Steyerberg, Ewout, Balmana, Judith, Stoffel, Elena, Cohn, David E, Backes, Floor J, Hopper, John L et al.
DOI: 10.1038/gim.2012.18

Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases.

PMID: 22402756
Revista: GENETICS IN MEDICINE
Año: 2012
Referencia: Genet Med. 2012 Jul;14(7):670-80. doi: 10.1038/gim.2012.18. Epub 2012 Mar 8.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Backes, Floor J; Balmana, Judith; Casey, Graham; Cohn, David E; de la Chapelle, Albert; Haile, Robert; Hampel, Heather; Hopper, John L; Jenkins, Mark A; Kastrinos, Fay et al.
DOI: 10.1038/gim.2012.18

Perioperative use of prothrombin complex concentrates.

PMID: 22357373
Revista: Minerva Anestesiologica
Año: 2012
Referencia: Minerva Anestesiol. 2012 Mar;78(3):358-68.
Factor de impacto: 2.656
Tipo de publicación: Revisión en revista internacional
Autores: Colomina, M J, Diez Lobo, A, Garutti, I, Gomez-Luque, A, Llau, J V, Pita, E et al.
DOI:

Perioperative use of prothrombin complex concentrates.

PMID: 22357373
Revista: Minerva Anestesiologica
Año: 2012
Referencia: Minerva Anestesiol. 2012 Mar;78(3):358-68.
Factor de impacto:
Tipo de publicación: Revisión en revista internacional
Autores: Colomina, M J; Diez Lobo, A; Garutti, I; Gomez-Luque, A; Llau, J V; Pita, E et al.
DOI:

Persistent Angina Pectoris, Cardiac Mortality and Myocardial Infarction During a 12 Year Follow-Up in 273 Variant Angina Patients Without Significant Fixed Coronary Stenosis.

PMID: 22835410
Revista: AMERICAN JOURNAL OF CARDIOLOGY
Año: 2012
Referencia: Am J Cardiol. 2012 Nov 1;110(9):1249-55. doi: 10.1016/j.amjcard.2012.06.026. Epub 2012 Jul 25.
Factor de impacto: 3.368
Tipo de publicación: Artículo en revista internacional
Autores: Figueras, Jaume, Domingo, Enric, Ferreira, Ignacio, Lidon, Rosa Maria, Garcia-Dorado, David et al.
DOI: 10.1016/j.amjcard.2012.06.026

Persistent Angina Pectoris, Cardiac Mortality and Myocardial Infarction During a 12 Year Follow-Up in 273 Variant Angina Patients Without Significant Fixed Coronary Stenosis.

PMID: 22835410
Revista: AMERICAN JOURNAL OF CARDIOLOGY
Año: 2012
Referencia: Am J Cardiol. 2012 Nov 1;110(9):1249-55. doi: 10.1016/j.amjcard.2012.06.026. Epub 2012 Jul 25.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Domingo, Enric; Ferreira, Ignacio; Figueras, Jaume; Garcia-Dorado, David; Lidon, Rosa Maria et al.
DOI: 10.1016/j.amjcard.2012.06.026

Personality profile of adult ADHD: The alternative five factor model.

PMID: 22386569
Revista: PSYCHIATRY RESEARCH
Año: 2012
Referencia: Psychiatry Res. 2012 Jun 30;198(1):130-4. doi: 10.1016/j.psychres.2011.11.006. Epub 2012 Mar 3.
Factor de impacto: 2.524
Tipo de publicación: Artículo en revista internacional
Autores: , , , , , , , , et al.
DOI: 10.1016/j.psychres.2011.11.006

Personality profile of adult ADHD: The alternative five factor model.

PMID: 22386569
Revista: PSYCHIATRY RESEARCH
Año: 2012
Referencia: Psychiatry Res. 2012 Jun 30;198(1):130-4. doi: 10.1016/j.psychres.2011.11.006. Epub 2012 Mar 3.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: ; ; ; ; ; ; ; ; et al.
DOI: 10.1016/j.psychres.2011.11.006

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

PMID: 22393084
Revista: JOURNAL OF CLINICAL ONCOLOGY
Año: 2012
Referencia: J Clin Oncol. 2012 May 10;30(14):1594-600. doi: 10.1200/JCO.2011.37.4207. Epub 2012 Mar 5.
Factor de impacto: 18.372
Tipo de publicación: Artículo en revista internacional
Autores: , , , , , , , , , et al.
DOI: 10.1200/JCO.2011.37.4207

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

PMID: 22393084
Revista: JOURNAL OF CLINICAL ONCOLOGY
Año: 2012
Referencia: J Clin Oncol. 2012 May 10;30(14):1594-600. doi: 10.1200/JCO.2011.37.4207. Epub 2012 Mar 5.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1200/JCO.2011.37.4207

Phase 1 Pharmacokinetic/Pharmacodynamic Study of MLN8237 - An Investigational, Oral, Selective Aurora A Kinase Inhibitor - In Patients With Advanced Solid Tumors.

PMID: 22753585
Revista: CLINICAL CANCER RESEARCH
Año: 2012
Referencia: Clin Cancer Res. 2012 Sep 1;18(17):4764-74. doi: 10.1158/1078-0432.CCR-12-0571. Epub 2012 Jul 2.
Factor de impacto: 7.742
Tipo de publicación: Artículo en revista internacional
Autores: , , , , , , , , , et al.
DOI: 10.1158/1078-0432.CCR-12-0571

Phase 1 Pharmacokinetic/Pharmacodynamic Study of MLN8237 - An Investigational, Oral, Selective Aurora A Kinase Inhibitor - In Patients With Advanced Solid Tumors.

PMID: 22753585
Revista: CLINICAL CANCER RESEARCH
Año: 2012
Referencia: Clin Cancer Res. 2012 Sep 1;18(17):4764-74. doi: 10.1158/1078-0432.CCR-12-0571. Epub 2012 Jul 2.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1158/1078-0432.CCR-12-0571

Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

PMID: 22162589
Revista: JOURNAL OF CLINICAL ONCOLOGY
Año: 2012
Referencia: J Clin Oncol. 2012 Jan 20;30(3):282-90. Epub 2011 Dec 12.
Factor de impacto: 18.372
Tipo de publicación: Artículo en revista internacional
Autores: Bendell, Johanna C, Rodon, Jordi, Burris, Howard A, de Jonge, Maja, Verweij, Jaap, Birle, Diana, Demanse, David, De Buck, Stefan S, Ru, Qinhua C, Peters, Malte et al.
DOI: 10.1200/JCO.2011.36.1360

Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

PMID: 22162589
Revista: JOURNAL OF CLINICAL ONCOLOGY
Año: 2012
Referencia: J Clin Oncol. 2012 Jan 20;30(3):282-90. Epub 2011 Dec 12.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Baselga, Jose; Bendell, Johanna C; Birle, Diana; Burris, Howard A; De Buck, Stefan S; de Jonge, Maja; Demanse, David; Goldbrunner, Michael; Peters, Malte; Rodon, Jordi et al.
DOI: 10.1200/JCO.2011.36.1360

Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumors.

PMID: 22382883
Revista: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Año: 2012
Referencia: Cancer Chemother Pharmacol. 2012 Jun;69(6):1467-75. doi: 10.1007/s00280-012-1856-4. Epub 2012 Mar 1.
Factor de impacto: 2.833
Tipo de publicación: Artículo en revista internacional
Autores: , , , , , , , , , et al.
DOI: 10.1007/s00280-012-1856-4

Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumors.

PMID: 22382883
Revista: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Año: 2012
Referencia: Cancer Chemother Pharmacol. 2012 Jun;69(6):1467-75. doi: 10.1007/s00280-012-1856-4. Epub 2012 Mar 1.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1007/s00280-012-1856-4

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

PMID: 22357447
Revista: ANNALS OF ONCOLOGY
Año: 2012
Referencia: Ann Oncol. 2012 Sep;23(9):2399-408. doi: 10.1093/annonc/mds011. Epub 2012 Feb 22.
Factor de impacto: 6.425
Tipo de publicación: Artículo en revista internacional
Autores: , , , , , , , , , et al.
DOI: 10.1093/annonc/mds011

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

PMID: 32018716
Revista: ANNALS OF ONCOLOGY
Año: 2012
Referencia: Ann Oncol. 2012 Sep;23(9):2399-2408. doi: 10.1093/annonc/mds011. Epub 2019 Dec 4.
Factor de impacto: 6.425
Tipo de publicación: Artículo en revista internacional
Autores: Markman, B, Tabernero, J, Siu, L, Chen, L C, Mita, M, Melendez Cuero, M, Stutvoet, S, Birle, D, Anak, O, Hackl, W et al.
DOI: 10.1093/annonc/mds011

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

PMID: 22357447
Revista: ANNALS OF ONCOLOGY
Año: 2012
Referencia: Ann Oncol. 2012 Sep;23(9):2399-408. doi: 10.1093/annonc/mds011. Epub 2012 Feb 22.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1093/annonc/mds011

Publicaciones

Buscador de publicaciones

Penile Squamous Cell Carcinoma.

[Perception of work environment of nurses in hospitals of the Spanish national health system. RN4CAST-Spain project].

[Perception of work environment of nurses in hospitals of the Spanish national health system. RN4CAST-Spain project].

Percutaneous interface biopsy in dry-aspiration cases of chronic periprosthetic joint infections: A technique for preoperative isolation of the infecting organism.

Percutaneous interface biopsy in dry-aspiration cases of chronic periprosthetic joint infections: A technique for preoperative isolation of the infecting organism.

Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases.

Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases.

Perioperative use of prothrombin complex concentrates.

Perioperative use of prothrombin complex concentrates.

Persistent Angina Pectoris, Cardiac Mortality and Myocardial Infarction During a 12 Year Follow-Up in 273 Variant Angina Patients Without Significant Fixed Coronary Stenosis.

Persistent Angina Pectoris, Cardiac Mortality and Myocardial Infarction During a 12 Year Follow-Up in 273 Variant Angina Patients Without Significant Fixed Coronary Stenosis.

Personality profile of adult ADHD: The alternative five factor model.

Personality profile of adult ADHD: The alternative five factor model.

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Phase 1 Pharmacokinetic/Pharmacodynamic Study of MLN8237 - An Investigational, Oral, Selective Aurora A Kinase Inhibitor - In Patients With Advanced Solid Tumors.

Phase 1 Pharmacokinetic/Pharmacodynamic Study of MLN8237 - An Investigational, Oral, Selective Aurora A Kinase Inhibitor - In Patients With Advanced Solid Tumors.

Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumors.

Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumors.

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

Patronato:

Colabora:

Acreditaciones: